Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Efalizumab modulates T cell function both in vivo and in vitro.

Koszik F, Stary G, Selenko-Gebauer N, Stingl G. Efalizumab modulates T cell function both in vivo and in vitro. J Dermatol Sci. 2010 Dec; 60(3):159-66.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.